State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee
Christine E. Ryan(Dana-Farber Cancer Institute), Matthew S. Davids(Dana-Farber Cancer Institute), Sandrine Roulland(World Wide Web Consortium), Sameer A. Parikh(Mayo Clinic), José I. Martín‐Subero(Institució Catalana de Recerca i Estudis Avançats), Júlia Almeida(Universidad de Salamanca), Deborah M. Stephens(University of North Carolina at Chapel Hill), Dinis Pedro Calado(Babraham Institute), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Miguel Alcoceba(Instituto de Investigación Biomédica de Salamanca), Erin M. Parry(Broad Institute), Inhye E. Ahn(Dana-Farber Cancer Institute), Jessica Okosun(Queen Mary University of London), Carsten Utoft Niemann(University of Copenhagen), Hendrik Veelken(University of Freiburg), Susan L. Slager(Mayo Clinic), Anton W. Langerak(Erasmus MC), Tait Shanafelt(Stanford University), Aswin Sekar(Boston University), Paolo Ghia(Vita-Salute San Raffaele University), Andy C. Rawstron(University of Leeds), Alberto Órfão(Universidad de Salamanca), Petra Langerbeins(University of Cologne)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Schizophrenia risk from complex variation of complement component 4
|Nature|2016|2.6k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k